. . . . . . "Our intention is not to create cloned human beings, Lanza said, but rather to make lifesaving therapies for a wide range of human disease conditions including diabetes, strokes, cancer, AIDS and neurodegenerative disorders such as Parkinson's and Alzheimer's disease." .